DrugCite
Search

MAGNEVIST

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Magnevist Adverse Events Reported to the FDA Over Time

How are Magnevist adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Magnevist, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Magnevist is flagged as the suspect drug causing the adverse event.

Most Common Magnevist Adverse Events Reported to the FDA

What are the most common Magnevist adverse events reported to the FDA?

Nephrogenic Systemic Fibrosis
4070 (6.21%)
Pain
2912 (4.44%)
Anxiety
1640 (2.5%)
Mobility Decreased
1518 (2.32%)
Skin Induration
1471 (2.25%)
Emotional Distress
1450 (2.21%)
General Physical Health Deteriorati...
1433 (2.19%)
Oedema Peripheral
1397 (2.13%)
Skin Hypertrophy
1321 (2.02%)
Skin Tightness
1317 (2.01%)
Scar
1259 (1.92%)
Show More Show More
Fibrosis
1256 (1.92%)
Pruritus
1188 (1.81%)
Joint Range Of Motion Decreased
1155 (1.76%)
Injury
1117 (1.7%)
Urticaria
1084 (1.65%)
Skin Fibrosis
972 (1.48%)
Pain In Extremity
930 (1.42%)
Erythema
879 (1.34%)
Musculoskeletal Stiffness
852 (1.3%)
Nausea
832 (1.27%)
Deformity
796 (1.21%)
Skin Discolouration
771 (1.18%)
Vomiting
770 (1.18%)
Joint Contracture
724 (1.1%)
Arthralgia
723 (1.1%)
Dyspnoea
706 (1.08%)
Joint Stiffness
667 (1.02%)
Anhedonia
653 (1%)
Skin Hyperpigmentation
603 (.92%)
Gait Disturbance
595 (.91%)
Skin Exfoliation
553 (.84%)
Muscular Weakness
548 (.84%)
Rash
532 (.81%)
Dry Skin
524 (.8%)
Hypoaesthesia
516 (.79%)
Asthenia
480 (.73%)
Skin Disorder
479 (.73%)
Extremity Contracture
442 (.67%)
Skin Plaque
409 (.62%)
Oedema
378 (.58%)
Burning Sensation
358 (.55%)
Muscle Tightness
307 (.47%)
Pain Of Skin
295 (.45%)
Paraesthesia
293 (.45%)
Abasia
282 (.43%)
Depression
282 (.43%)
Fatigue
282 (.43%)
Pruritus Generalised
279 (.43%)
Sneezing
268 (.41%)
Skin Lesion
263 (.4%)
Cough
255 (.39%)
Muscle Contracture
237 (.36%)
Dizziness
233 (.36%)
Myalgia
231 (.35%)
Rash Macular
220 (.34%)
Joint Swelling
214 (.33%)
Skin Ulcer
214 (.33%)
Rash Papular
205 (.31%)
Back Pain
190 (.29%)
Quality Of Life Decreased
189 (.29%)
Throat Irritation
184 (.28%)
Chest Discomfort
176 (.27%)
Bone Pain
174 (.27%)
Motor Dysfunction
167 (.25%)
Swelling
160 (.24%)
Chest Pain
158 (.24%)
Contrast Media Reaction
151 (.23%)
Feeling Hot
150 (.23%)
Throat Tightness
150 (.23%)
Flushing
147 (.22%)
Nasal Congestion
147 (.22%)
Hyperhidrosis
141 (.22%)
Anaphylactic Reaction
138 (.21%)
Loss Of Consciousness
128 (.2%)
Eye Swelling
127 (.19%)
Skin Swelling
126 (.19%)
Skin Burning Sensation
125 (.19%)
Hyperkeratosis
124 (.19%)
Headache
123 (.19%)
Convulsion
118 (.18%)
Dysphagia
117 (.18%)
Hypersensitivity
117 (.18%)
Exfoliative Rash
109 (.17%)
Skin Fissures
108 (.16%)
Swelling Face
108 (.16%)
Tremor
106 (.16%)
Dysstasia
105 (.16%)
Insomnia
104 (.16%)
Injection Site Pain
103 (.16%)
Rash Pruritic
103 (.16%)
Pyrexia
102 (.16%)
Skin Atrophy
95 (.14%)
Discomfort
94 (.14%)
Musculoskeletal Pain
93 (.14%)
Blister
91 (.14%)
Septic Arthritis Staphylococcal
91 (.14%)
Activities Of Daily Living Impaired
89 (.14%)
Blood Pressure Increased
88 (.13%)
Pigmentation Disorder
87 (.13%)
Off Label Use
85 (.13%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Magnevist, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Magnevist is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Magnevist

What are the most common Magnevist adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Magnevist, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Magnevist is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Magnevist According to Those Reporting Adverse Events

Why are people taking Magnevist, according to those reporting adverse events to the FDA?

Nuclear Magnetic Resonance Imaging
3904
Nuclear Magnetic Resonance Imaging ...
1439
Angiogram
789
Drug Use For Unknown Indication
632
Nuclear Magnetic Resonance Imaging ...
314
Product Used For Unknown Indication
305
Show More Show More
Imaging Procedure
138
Arthrogram
110
Venogram
56
Scan With Contrast
49
Diagnostic Procedure
47
Nuclear Magnetic Resonance Imaging ...
36
Scan
30
Computerised Tomogram
29
Back Pain
23
Fistulogram
23
Headache
22
Angioplasty
20
Arteriogram Carotid
18
Nuclear Magnetic Resonance Imaging ...
17
Convulsion
17
Abdominal Pain
15
Mass
13
Arthroscopy
13
Renal Mass
13
Arteriogram Renal
12
Multiple Sclerosis
12
Computerised Tomogram Abdomen
11
Arteriogram Coronary
11
Breast Cancer
11
Arteriogram
10
Osteomyelitis
10
Renal Failure
9
Joint Injury
9
Investigation
8
Scan Brain
8
Arthralgia
8
Asthenia
8
Spinal Myelogram
7
Vertigo
7
Magnetic Resonance Cholangiopancrea...
7
Brain Neoplasm
7
Renal Aneurysm
7
Catheter Placement
6
Migraine
6
Musculoskeletal Pain
6
Acoustic Neuroma
6
Nuclear Magnetic Resonance Imaging ...
6
Deafness
6
Pain In Extremity
5
Joint Swelling
5

Drug Labels

LabelLabelerEffective
MagnevistBayer HealthCare Pharmaceuticals Inc.29-MAR-12
MagnevistBayer HealthCare Pharmaceuticals Inc.29-MAR-12

Magnevist Case Reports

What Magnevist safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Magnevist. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Magnevist.